Activating NR2F6 potentially leads to inhibiting the immune system and should lead
to therapies... is “a proposition assumed as a premise in an argument.”
The world is literally being asked to buy this hypothetical proposition by RGBP’s CEO
Before you buy the mega-hypothesis, scrutinize the seller of this stuff. Is RGBP’s CEO a proven seller?
From what my intern has reported, the only thing proven is the CEO cashing a large paychecks for a long time without a dimes worth of sales, no products developed, and never even bringing a potential product into phase 1 testing.
Koos sells the “should lead” like HemaX should ........
Should’s = Trips
Beware of the seller of hypothesis. Buy the proven sellers elsewhere
News 
Market Data 
Discover 
